ARCHIVES

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

August 2, 1996

Foreign awards Less Than 1% Of NCI Budget

June 22, 1990

Studies Seek to Identify High-Risk Groups to Justify Mammography Screening at 40

May 4, 2012

DCBDC Advisors Table Gl SPORE Over Pancreatic Cancer Research Requirement

March 17, 1995

Smokeless Tobacco Consensus Conference Slates in Health Risks

August 16, 1985

Congressman Obey Attacks NCI for Not Supporting Basic Research

January 23, 1976